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Glioblastoma is recognized as World Health Organization (WHO) grade IV glioma with
an aggressive growth pattern. The current clinical practice in diagnosis and prognosis of
Glioblastoma using MRI involves multiple steps including manual tumor sizing. Accurate
identification and segmentation of multiple abnormal tissues within tumor volume in
MRI is essential for precise survival prediction. Manual tumor and abnormal tissue
detection and sizing are tedious, and subject to inter-observer variability. Consequently,
this work proposes a fully automated MRI-based glioblastoma and abnormal tissue
segmentation, and survival prediction framework. The framework includes radiomics
feature-guided deep neural network methods for tumor tissue segmentation; followed
by survival regression and classification using these abnormal tumor tissue segments
and other relevant clinical features. The proposed multiple abnormal tumor tissue
segmentation step effectively fuses feature-based and feature-guided deep radiomics
information in structural MRI. The survival prediction step includes two representative
survival prediction pipelines that combine different feature selection and regression
approaches. The framework is evaluated using two recent widely used benchmark
datasets from Brain Tumor Segmentation (BraTS) global challenges in 2017 and 2018.
The best overall survival pipeline in the proposed framework achieves leave-one-out
cross-validation (LOOCV) accuracy of 0.73 for training datasets and 0.68 for validation
datasets, respectively. These training and validation accuracies for tumor patient survival
prediction are among the highest reported in literature. Finally, a critical analysis of
radiomics features and efficacy of these features in segmentation and survival prediction
performance is presented as lessons learned.
Keywords: glioblastoma, segmentation, neural network, radiomics, survival prediction

INTRODUCTION
The World Health Organization (WHO) identifies Glioblastoma as a highly aggressive grade IV
glioma. Glioblastoma is known for the presence of anaplastic glial cells along with high mitotic
activity and dense cellularity, as well as the increase in microvascular proliferation (Ohgaki,
2005; Louis et al., 2007; Bleeker et al., 2012). The aggressive and infiltrative growth pattern of
Glioblastoma makes curative treatment impossible, which reduces the median survival rate to less
than 2-years for most patients (Johnson et al., 2013). Recently, the interest has shifted toward
replacing invasive methods for tumor subtyping that predict clinical outcome with non-invasive
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segmentation and survival prediction performance compared to
the state-of-the-art methods.

methods (Brown et al., 2008; Itakura et al., 2015; Yang et al.,
2015). Different studies (Vartanian et al., 2014; Hu et al., 2015;
Liu et al., 2017) discussed Glioblastoma heterogeneity and its
implication on the clinical outcome. Glioblastoma heterogeneity
can be examined through radiology images such as Magnetic
Resonance Imaging (MRI) (Yang et al., 2002, 2015; Emblem
et al., 2008). Quantitative radiomic imaging features (henceforth,
radiomics) computed from MRI can be utilized for clinical
outcome prediction (Lacroix et al., 2001; Lao et al., 2017;
Shboul et al., 2017) and molecular classifications (Gutman et al.,
2013; Jain et al., 2013). An accurate detection and segmentation
of different abnormal tumor tissues is essential in planning
treatment therapy, diagnosis, grading, and survival prediction.
Few works (Pope et al., 2005; Gutman et al., 2013; Aerts
et al., 2014) have proposed different methods for predicting the
survivability of patients with brain tumors. Pope et al. (2005)
use different subtype tumor volumes, the extent of resection,
location, size and other imaging features in order to evaluate
the capability of these features to predict survival. Gutman
et al. (2013) use a comprehensive visual feature set known
as Visually AcceSAble Rembrandt Images (VASARI) in order
to predict survival, and correlate these features for genetic
alterations and molecular subtypes. Aerts et al. (2014) predict
survival by quantifying a large number of radiomic image features
including shape and texture in computed tomography images of
lung and head-and-neck cancer patients. Several of the survival
prediction studies utilize regression survival (Guinney et al.,
2017; Passamonti et al., 2017) models such as the proportional
hazard method while a few others utilize machine learning
methods to predict survival (Macyszyn et al., 2015; Shouval et al.,
2017; Kirienko et al., 2018).
Among many different feature-based and feature-learned
deep neural network-based abnormal tumor tissue segmentation
(Havaei et al., 2017; Mlynarski et al., 2018; Shah et al., 2018;
Cheplygina et al., 2019) and survival prediction methods (Islam
et al., 2013; Reza and Iftekharuddin, 2014; Vidyaratne et al.,
2018) with varying performances as discussed above, there is a
need to understand the effect of feature-guided deep radiomics
for both tumor segmentation and patient survival prediction.
A feature-guided deep radiomics approach is expected to
benefit from known radiomics features that are already proven
effective to guide discovery of unknown features using deep
learning methods. Consequently, this work proposes a fully
automated two-step survival prediction framework for patients
with glioblastoma: radiomics feature-guided deep neural network
methods for automated tumor tissue segmentation; and overall
survival regression classification using these tumor segments
and other relevant features using raw structural MRI data
(Reza and Iftekharuddin, 2014; Shboul et al., 2017). The
known radiomics are multiresolution fractal texture features
that have shown efficacy in brain tumor segmentation (BraTS)
in prior studies (Iftekharuddin et al., 2003; Islam et al.,
2008; Ahmed et al., 2009; Reza and Iftekharuddin, 2014;
Vidyaratne et al., 2018). The proposed framework is evaluated
using two recent widely used benchmark datasets from BraTS
global challenges in 2017 and 2018, respectively. Our results
suggest that the proposed framework achieves better tumor
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MATERIALS AND METHODS
The overall pipeline with each processing block used for tumor
segmentation and survival prediction is shown in Figure 1.
This fully automated method proposes a two-step survival
prediction framework: radiomics feature-guided deep neural
network methods for automated tumor tissue segmentation;
and overall survival regression classification using these tumor
segments and other relevant features. The proposed multiple
abnormal tumor tissue segmentation step effectively captures
both local and global feature-guided deep radiomics information
in structural MRI. The survival prediction step includes two
representative survival prediction pipelines that experiment with
different feature selection and regression approaches.

Tumor Segmentation
The tumor segmentation methods are summarized below.

Feature-Based Brain Tumor Segmentation
This method (Figure 2A) utilizes several of our prior robust
feature extraction algorithms to include piecewise triangular
prism surface area (PTPSA) (Iftekharuddin et al., 2003), and
multi-fractional Brownian motion (mBm) (Islam et al., 2008).
These methods capture the non-local intensity and spatially
varying texture observed in abnormal tumor tissues. In addition,
several other generic features such as Texton, and raw intensity
are used as input to a random forest (RF) based classifier to obtain
the multi-class abnormal tumor tissue segmentation (Ahmed
et al., 2009; Reza and Iftekharuddin, 2014).

Feature-Learned Brain Tumor Segmentation Using
Deep CNN
This method essentially transforms the segmentation problem
into an intensity-based image classification task. Localized 2D
patches surrounding each pixel subjected to classification are
extracted from MRI and are used as input to deep CNN
architecture. We set the size of the input patch as 33 × 33 for
tumor segmentation (Vidyaratne et al., 2018). The detailed CNN
design for this method is shown in Figure 2B.

Feature-Learned Brain Tumor Segmentation Using
Deep U-Net
This method utilizes a CNN based U-Net model (Ronneberger
et al., 2015; Dong et al., 2017) to obtain brain tumor
segmentation. U-Net model is known for end-to-end data
processing. Unlike patch based CNN segmentation pipeline
where the model only sees a localized region of the brain, the
U-Net in this work captures global information from different
regions of the brain, which is essential to achieve robust
segmentation performance. The U-Net architecture utilized in
this work is implemented following the work in Dong et al.
(2017). More specifically, the architecture consists of a downsampling (encoding) and an up-sampling (decoding) stage.
The down-sampling stage has five convolutional blocks each
consisting of two convolutional layers with a filter size of 3 × 3
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FIGURE 1 | Brain tumor segmentation pipelines (left) using: (A) feature-based high-grade tumor segmentation using RF; (B) feature-less segmentation using Deep
CNN, U-Net, and FCN; and (C) semantic label fusion using feature-less and feature-based. Survival prediction pipelines (right) are started with (D) feature extraction
and are trained using (E) tree-regression-based RF survival prediction, and (F) XGBoost-based survival prediction.
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FIGURE 2 | Overall segmentation pipelines used in the proposed methods. (A) Feature-based High-grade tumor segmentation using RF; (B) detailed architecture of
the CNN based high-grade tumor segmentation; (C) Low-grade tumor segmentation with U-Net (detailed architecture); (D) architecture of brain tumor segmentation
(BraTS) using FCN; and (E) general pipeline of BraTS fusion by feature-based and feature-learned model.
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and stride of 1 followed by maxpooling with stride 2 × 2. The
upsampling stage consists of deconvolution layer with a filter
size of 3 × 3 and stride of 2 × 2 which doubles the size of
the feature maps. Rather than using regular cross-entropy based
loss function, we utilize a soft dice metric based loss function
to train the U-Net model (Milletari et al., 2016). The soft dice
is a differentiable form of the original dice similarity coefficient
(DSC) which is the most widely used metric to evaluate tumor
segmentation performance. The model is trained using minibatch gradient descent (GD) technique which minimizes the soft
dice cost function. Figure 2C shows the detailed architecture of
the U-Net model to perform the BraTS task.

Survival Prediction

Feature-Learned Brain Tumor Segmentation Using
Fully Convolutional Networks

Feature Extraction

The survival prediction model includes prediction of survival
risk classification (short, medium, and long-term survival).
Subsequently, an overall survival regression is performed based
on the survival risk class label. Both classification and regression
models are trained on quantitative- radiomics features obtained
from the segmented tumor. Recursive feature selection (RFS)
method is used to select the features that are used in the
classification model. Finally, Cox regression is used as a feature
selection method in the overall survival regression model. Three
overall regression models are trained: long-regression model,
mid-regression model, and short regression model.
Feature extraction is the first step of the overall survival
prediction task. Different quantitative imaging features
(of around 31,000) are extracted from the different types of
segmented abnormal tissues (edema, enhancing tumor, and
tumor core) obtained in the previous step. These features include
texture, volumetric and area-related features, histogram-graph
features, and Euler characteristics (vertices, edges, and faces). The
heterogeneity in Glioblastoma may be quantified using texture
and histogram-graph features; while the shape of the tumor may
be effectively captured using volumetric and Euler characteristic
features (Pope et al., 2005; Aerts et al., 2014; Rathore et al., 2016).
A detailed breakdown of the extracted features is as follows: a
total of 1107 texture features (Vallières et al., 2015) are computed
from raw MRI sequences, and the features are extracted from
eight texture representations of the tumor volume [Texton filters
(Leung and Malik, 2001); texture-fractal characterization using
both our PTPSA (Iftekharuddin et al., 2003) modeling and
multi-resolution mBm (Islam et al., 2008) modeling; and the
characterization Holder Exponent (Ayache and Véhel, 2004)
modeling of the tumor region]. Furthermore, six histogrambased statistics (mean, variance, skewness, kurtosis, energy, and
entropy) features are extracted from the edema, enhancing
tumor, and necrosis tissues.
Moreover, 13 volume-related features are considered: the
volume of the whole tumor, the volume of the whole tumor
with respect to the brain, the volume of sub-regions (edema,
enhancing tumor, and necrosis) divided by the whole tumor, the
volume of sub-regions (edema, enhancing tumor, and necrosis)
divided by the brain, the volumes of the enhancing tumor
and necrosis divided by the edema, the summation of the
volume of the edema and enhancing tumor, the volume of the
edema divided by the summation of the volume of enhancing
tumor and necrosis, and the volume of the necrosis divided
by the summation of the volume of the edema and enhancing
tumor. The tumor locations and the spread of the tumor in
the brain are computed. Another nine area-related properties
(area, centroid, perimeter, major axis length, minor axis length,
eccentricity, orientation, solidity, and extent) are computed from
three viewpoints (x, y, and z-axes) of the whole tumor.
Furthermore, a total of 832 features are extracted from the
histogram graph of the different modalities of the whole tumor,
edema, enhancing and necrosis regions. These features represent
the frequency at different intensity bins (of 11,15, and 23) and

Fully convolutional networks (FCNs) have been successfully used
for many image processing and computer vision tasks (Long
et al., 2015; Zhao et al., 2016). FCNs build FCNs that take
an input of arbitrary size and produce a correspondingly sized
output of relevant characteristics with efficient inference and
learning. Accordingly, FCN contains only convolutional layers.
It removes any redundancy when computing classification maps
on large inputs. The architecture also features an encode (downsampling) and a decode (up-sampling) stage. The encode stage
of the proposed architecture has five convolutional blocks. Each
block is composed of two convolutional layers with a filter size of
3 × 3 and stride of 1 followed by maxpooling with stride 2 × 2.
The decode stage consists of deconvolution layers with a filter
size of 3 × 3 and stride of 2 × 2 which doubles the size of the
feature maps. The framework of the proposed method is shown in
Figure 2D, which uses VGG-11 (Simonyan and Zisserman, 2014)
as a pre-trained model.

Semantic Label Fusion of Feature-Based and
Feature-Learned Deep Radiomics for Improved
Tumor Segmentation
The different deep radiomics-based models discussed above are
first independently implemented and trained for multi-class
abnormal tumor tissue segmentation. In order to complement
both feature-based and feature-learned radiomics methods, we
implement a label fusion method (Figure 2E) for improved
tumor segmentation. The label fusion is then performed to obtain
the fused output Fiv for volume v as follows:
Fiv = Ui

[

Ci ;

(1)

i∈v

WhereUi , and Ci denote the U-Net and FCN outputs given
MRI volume v, respectively.
The outputs of U-Net and FCN architectures offer excellent
specificity, albeit with varying sensitivity performance. The union
operation in equation (1) essentially preserves the specificity
while improving the sensitivity by combining the within-class
regions from each output. Similarly, this method is used for
label fusion between the patch-wise CNN based segmentation
algorithm and the hand-crafted feature-based algorithm for
better segmentation performance.
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study is not large enough to ensure good training in a neural
network setting.

the bins of the max frequency. Finally, we compute the Euler
characteristic (Turner et al., 2014) of the whole tumor, edema,
enhancing and necrosis, for each slice. The Euler characteristic
features are computed on the tumor curve, at 100 points, and
at 72 different angles. Then, the Euler characteristic features
are integrated over all the slices. As a result, each patient is
represented by 4 (whole tumor, edema, enhancing, and necrosis)
Euler characteristic feature vectors. Each vector has a size of 7200
(100 points × 72 angles).

RESULTS
Dataset
This study uses BraTS18 training, validation and testing dataset
(Menze et al., 2015; Bakas et al., 2017a,b), and BraTS17 training,
validation, and testing datasets for patient survival prediction
analysis. Both BraTS17 and BraTS18 datasets contain a total of
163 Glioblastoma [high grade glioma (HGG)] cases for training,
with an overall survival, defined in days, and the age of patient
at diagnosis, defined in years. The training dataset provides four
modalities [T1, post-contrast T1-weighted (T1Gd), T2-weighted
(T2), and T2 Fluid Attenuated Inversion Recovery (FLAIR)]
along with the ground truth segmentation of multiple abnormal
tissues (enhancing, edema, necrosis, and non-enhancing) in the
tumor. Overall survival risk is classified into three survival
groups: long (greater than 15 months), medium (between 10 and
15 months), and short (less than 10 months). In addition, for
validation purposes, we use the validation datasets of BraTS17
and BraTS18. BraTS17 validation dataset consists of 33 cases
while that for BraTS18 consists of 28 cases for overall survival
prediction purposes. BraTS17 testing dataset consists of 95 cases
while that for BraTS18 offers 77 cases for testing the overall
survival prediction performance.

Survival Prediction Models
Two different survival prediction models are proposed for
survival prediction. The first model is a tree-based method for
overall-survival regression prediction using RF regression model.
We have employed RF due to its efficiency, robustness and
the flexibility in utilization for both multi-class classification
and regression tasks (Breiman, 2001). Additionally, RF does not
require extensive hyper-parameter tuning, and is resilient to
overfitting. These traits make RF preferable over more common
models such as artificial neural networks especially when the
training data is limited. The complete pipeline for the survival
regression using RF is illustrated in Figure 3A. This model uses
significant, predictive and important features selected from the
above-mentioned texture, histogram-graph, and volumetric and
area-related features. A three-step feature selection method is
utilized as follows. A univariate cox regression is fitted on every
extracted feature, and features with p-value less than 0.05 are
considered as significant. A second univariate cox regression is
fitted on the quantitative copy of the significant features. The
quantitative copy is obtained by thresholding the significant
feature around its median value. The last step is performed
to ensure that each significant feature is also able to split the
data set into long vs. short survival. Then, RF regression model
with tenfold cross validation is used to evaluate the model
at each iteration.
The model in Figure 3A is used as a baseline to obtain
a second more comprehensive survival prediction pipeline
as shown in Figure 3B. We incorporate additional features
such as Euler characteristics. The features for the updated
model are then selected using RFS method as follows. First,
we perform RFS1 on the Euler features alone. Next, another
RFS2 on the remaining features (texture, volumetric, histogramgraph based) is performed. In addition, the overall-survival
regression model uses Cox regression to select significant features
with p-value < 0.05. Moreover, we introduce a state-of-theart Extreme Gradient Boosting (XGBoost) (Chen and Guestrin,
2016) based regression technique for stepwise survival risk
classification and overall-survival regression prediction using
the selected features. The XGBoost based regression model
is applied to each of the three groups (short, medium, and
long) to obtain survival duration in the number of days,
respectively. One of the major advantages of XGBoost its
utilization of L1 and L2 regularization. L1 regularization
handles sparsity, whereas L2 regularization reduces overfitting
(Chen and Guestrin, 2016).
It is worth noting that we have not utilized any neural network
model for the survival prediction because the sample size in this

Frontiers in Neuroscience | www.frontiersin.org

Overall Survival Prediction Framework
Evaluation
As discussed in the Methods section, the proposed framework
consists of several feature-based and feature-guided deep
radiomics-based automated BraTS methods and two distinct
deep radiomics based automated survival prediction pipelines.
Accordingly, we obtain extensive performance evaluation using
two pipelines: the first one combines CNN-based patch-wise
segmentation algorithm, radiomics feature-based segmentation
algorithm, and RF based survival prediction method (henceforth
SP1), while the second combines U-Net and FCN based
segmentation methods with the XGBoost based survival
prediction algorithm (henceforth SP2). We first participated
in the BraTS 2017 challenge and the specific combination of
machine learning methods with RF survival prediction model
(known as SP1) offered the best overall performance in this
Challenge. We subsequently participated in the BraTS 2018
challenge and the augmented model (known as SP2) offered the
best performance using the validation dataset. The mean dice
segmentation performance (of enhancing tumor, whole tumor,
and tumor core) for SP1 and SP2 is illustrated in Table 1. The
mean dice segmentation metrics for different sub-tissues are
evaluated using the online evaluation platform of the BraTS
challenge (CBICA IPP at1 ). A detailed performance analysis of
U-Net, FCN and their sematic-label fusion results are illustrated
in Table 2. Figure 4 shows an example of segmentation outcomes
using U-Net, FCN and semantic-label fusion of U-Net and FCN.
1
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For SP1 the survival prediction features are the age and
40 texture and volumetric features. The distribution of the
40 features is as follows: 12 features extracted from Texton
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representations of the tumor, 6 features represent the histogram
of the abnormal tissues, 5 from the raw MR modality of the tumor
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[95% confidence intervals (CI): 0.655–0.797] for the BraTS18
training dataset.
First, we establish the performance of both SP1 and SP2
methods using the BraTS17 and BraTS18 training, and validation
datasets. The training dataset performance is obtained through
LOOCV analysis. The performance evaluation of methods using
BraTS validation datasets is restricted to the online evaluation
platform of the organizer of the BraTS challenge and must be
performed during a specific time period during the challenge.
Note that the second pipeline (SP2) is developed after the BraTS
2017 challenge is concluded, and hence 2017 validation portal is
no longer available for evaluation. However, a fair comparison
between the pipelines can still be obtained through the training
data evaluations and the validation evaluations of respective
challenge years. The results are summarized in Tables 1, 3.
The results in Table 1 for training and validation illustrate
that SP2 model offers better performance in accuracy over
that of SP1 model. SP2 model also obtains improvement over
SP1 in validation MSE. This performance improvement may
be attributed to improved abnormal tumor tissue segmentation
as well as the use of additional features obtained using better
feature selection and regression methods. Note that SP1 model
has been ranked the first in the BraTS 2017 challenge for
survival prediction category among 17 teams globally. The
overall high MSE for survival prediction is particularly due to
the wide range within long term survival category resulting in
large prediction errors. Further, note that the MSE of SP2 for
the BraTS18 training is the sum of the three MSE (Table 4)
values obtained for the short-, medium-, and long-regression
models shown in Table 4. Finally, the test results for both SP1
for BraTS17 and SP2 for BraTS18 in Table 1 show that SP1
performed better in patient-survival prediction than that for
SP2. This performance difference for SP1 and SP2 models is
further analyzed below.

TABLE 1 | Performance of SP1, SP2, and modified-SP2 methods with BratS17
and BraTS18 datasets.

Model/dataset

Survival prediction

Segmentation

performance

performance

Accuracy

MSE

Dice
enhanced
tumor

Dice
whole
tumor

Dice
tumor
core

SP1/BraTS17
training

0.67

78,929

–

–

–

SP1/BraTS17
validation

0.667

2,09,908

0.746

0.815

0.698

SP1/BraTS17 test

0.579

2,45,780

0.733

0.832

0.725

SP2/BraTS18
training

0.73

91,585

–

–

–

SP2/BraTS18
validation

0.679

1,53,466

0.765

0.876

0.761

SP2/BraTS18 test

0.519

3,67,240

0.705

0.857

0.767

RF-SP1/BraTS18
validation

0.464

1,70,737

–

–

–

XGBoostSP2/BraTS17
validation

0.636

2,18,097

–

–

–

ModifiedSP2/BraTS18
training

0.718

99,358

–

–

–

ModifiedSP2/BraTS18
validation

0.679

1,27,697

–

–

–

The evaluation of validation is performed using the online evaluation platform of
CBICA IPP (https://ipp.cbica.upenn.edu).

TABLE 2 | Performance of U-Net, FCN and their Semantic-label fusion using
BraTS18 validation dataset.
Model

Dice enhanced
tumor

Dice whole
tumor

Dice tumor
core

FCN

0.706

0.850

0.727

U-Net

0.697

0.835

0.719

Semantic-label fusion

0.714

0.861

0.740

Comparative Evaluation of Survival
Prediction Performance With SP1
and SP2
Table 3 shows the confusion matrix of both SP1 and SP2 and
relevant statistics for each class in the classification training
model for survival risk prediction. The sensitivity and balanced
accuracy of the medium survival group in SP2 is the lowest when
compared to the other two survival groups.
The top four important features as ranked by XGBoost are:
tumor extent in z-axis, the width of the enhance tumor computed
from x-axis point of view, contour around the edema contour and
enhance tumor. The mean value of each of these four features is
able to significantly (p-value < 0.05) stratify the 163 cases into
two risk groups (low-risk and high-risk) as illustrated in Figure 5.
The second step in the survival prediction is to obtain
individual regression training models corresponding to the short,
medium, and long survival classes. These short-, medium-, and
long-regression models use features selected distinctly for each
survival class using Cox regression (with p-value < 0.05). The
number of significant features selected for the short-, medium-,
and long-regression models are 83, 51, and 148, respectively.

and sub-regions, 4 describe the volume of the tumor and the subregions, and 4 features are extracted from the tumor area and
major axis length.
In comparison, as discussed above and shown in Figure 3B
for SP2, all relevant features are extracted from the ground truth
cases available with BraTS18 training dataset. The subsequent
RFS for Euler features (28,000) alone generates 39 features.
The distribution of the 39 Euler features includes: 16 features
computed around the contour of ET, 16 features computed
around that of WT, and 7 features computed around that of
edema, respectively. The application of RFS on the remaining
features produces additional 23 texture features, 4 histogram
graph features, and 8 area features of the edema, ET, and WT,
respectively. The XGBoost with leave-one-out cross-validation
(LOOCV) is employed on the selected 74 features and the
age to predict three corresponding survival classes (short,
medium, and long). This yields a classification accuracy of 0.73
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FIGURE 4 | Example input slices from BraTS18 training dataset and segmentation outcomes: (A) Flair sequence; (B) the ground truth; (C) the segmentation
outcome of U-Net; (D) the segmentation outcome of FCN; and (E) semantic label fused segmentation.

TABLE 3 | Confusion matrix of SP1, SP2, and modified-SP2, and some statistics derived from the confusion matrix based on each survival label in the training model.

Long

SP1 2017

SP2 2018

Modified-SP2 2018

Reference

Reference

Reference

Med

Low

Long

Med

Low

Long

Med

Low

4

Predictions
Long

32

7

10

43

13

4

44

11

Med

24

34

12

5

18

3

7

18

6

Low

0

1

43

8

11

58

5

13

55

Total number of cases

56

42

65

56

42

65

56

42

65

Sensitivity

0.571

0.810

0.662

0.768

0.429

0.892

0.786

0.429

0.846

Specificity

0.841

0.702

0.990

0.841

0.934

0.806

0.860

0.886

0.816

Balanced accuracy (Sen + Spec)/2

0.706

0.756

0.826

0.804

0.681

0.849

0.823

0.657

0.831

Positive prediction value (PPV)

0.653

0.486

0.977

0.717

0.692

0.753

0.745

0.581

0.753

Negative prediction value (NPV)

0.789

0.914

0.815

0.874

0.825

0.919

0.885

0.817

0.889

Statistics

TABLE 4 | Performance of LOOCV of the three regression models in SP2 and modified-SP2 in the XGBoost overall survival model.
SP2

Modified-SP2

Root mean square
error (RMSE)

MSE

Mean absolute
error (MAE)

Root mean square
error (RMSE)

MSE

Mean absolute
error (MAE)

Long-regression model

294.177

86,540

217.714

302.069

91,246

209.253

Medium-regression model

35.629

1,269

28.190

40.702

1,657

34.971

Short-regression model

61.449

3,776

50.402

80.340

6,455

65.094

Table 4 illustrates the performance of LOOCV with XGBoost
for the selected features using specified survival risk cases in
BraTS18 training cases.
Note that the wide range of the overall survival of the longsurvival group (greater than 15 months) may cause the RMSE of

Frontiers in Neuroscience | www.frontiersin.org

the long-regression model to have the highest RMSE (Table 4).
This also may cause the high mean square error when using the
validation dataset (Table 1). The range of the overall survival
of the short-survival group is 10 months, whereas the mediumsurvival group is 5 months.
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FIGURE 5 | Kaplan Meier of the top four important features used in SP2. The features are thresholded around its mean value to stratify the 163 subjects into two
groups: high risk group (red line), and low risk group (blue line). The features are (A) tumor extent; (B) enhance tumor width; (C) contour around the edema; and (D)
contour around the enhance tumor. The shaded area indicates the 95% confidence interval.

Critical Analysis of Features and
Performance of the Survival
Prediction Pipelines

Neighbor Embedding (Maaten and Hinton, 2008) (t-SNE). First,
t-SNE is used to explore the features obtained from different
abnormal tissue types from the segmented tumor region and
analyze the effect of these features on the performance of
the survival prediction task using BRAST 2017 and BRAST
2018 dataset.
For the SP1 pipeline, we extract a total of 40 features from
the sub-tissue types of the segmented tumor region. The features
extracted in SP1 are as follows: 36 features for whole tumor,
2 features for enhanced tumor, and 2 features for edema.
Figures 6A–C shows a visualization of these features across
different abnormal tissue types for BraTS17 training, validation
and testing data, respectively. These figures demonstrate that
the extracted features for segmentation offer clear discrimination

This section provides a critical analysis of the features and their
effect on the survival prediction performance. As mentioned
in the previous sections, the features that are derived from
different abnormal tissue types of the segmented tumor region
significantly contribute to the survival prediction performance
(the abnormal tissue segmentation dice performance of SP1
and SP2 are illustrated in Table 1). Accordingly, we visualize
the features extracted from different abnormal tissue types
of the segmented tumor. The visualization is performed
using one of the most widely used high-dimensional data
visualization techniques known as t-Distributed Stochastic
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among different abnormal tissue types in the tumor. This
demonstrates the effectiveness of the segmentation pipeline in
SP1. Next, we visualize the feature clusters for patient survival
categories: long, medium and short term. In this case we consider
all 40 features obtained from the 163 BraTS17 training data as
mentioned above and explore the grouping against the tumor
risk labels using the t-SNE technique. Figure 7 shows the
visualization of the corresponding features for long, medium
and short risk labels. Note that all the visualization outcomes
shown are obtained after extensive hyper-parameter tuning of
t-SNE to produce the best possible results. Figure 7 demonstrates
that though there is some separation of corresponding features
between the long and short categories, the medium category is
mixed with both long and short categories. This suggests that it
is still difficult to visualize a clear separation of extracted features
for survival prediction task with the available patient dataset for
this study. The corresponding survival prediction performance of
SP1 pipeline using testing dataset is as shown in Tables 1, 3. As
mentioned above, though the SP1 pipeline was ranked the first
place in BraTS 2017 challenge, the feature distribution in Figure 7
suggests inherent challenge in extracting representative features
for survival prediction task.
Next, we explore the features and their effect on the
performance of our SP2 pipeline using the BraST18 dataset. We
extract a total of 74 features and the age for the SP2 pipeline.
The features extracted in SP2 are as follows: 43 features for
whole tumor, 22 features for enhanced tumor, and 8 features
for edema, and 1 feature for necrosis. Figures 8A–C shows
a visualization of these features across different tissue types
for BraTS18 training, validation and testing data, respectively.
Figure 8 demonstrates that these features also offer a clear
separation for different abnormal tissue types in the tumor.
Therefore, this further demonstrates the effectiveness of our
segmentation pipeline in SP2 and verifies that the extracted
features are highly representative of the different abnormal tissue
regions (the abnormal tissue segmentation dice performance of
SP2 is illustrated in Table 1). Subsequently, Figure 9 shows the
visualization of the 74 features in terms of long, medium and
short risk labels using the 163 sample BraTS18 training data.
Our analysis suggests that the tSNE technique again fail to group
the features in long, medium and short categories. Though there
is some separation between the corresponding features for long
and short categories, the features for medium category mixes
with both short and long categories for multiple subjects, quite
similarly to the visualization of SP1. This poor separation may
still be due to the lack of sufficient representative strength of
the features for categorizing different risk labels. Consequently,
Table 1 shows that our proposed SP2 pipeline achieves 0.73,
0.679, and 0.519 accuracy on the BraTS18 training, validation
and testing data.
Additionally, we validate our RF survival prediction in SP1
(RF-SP1) using BraTS18 validation set. We also validate XGBoost
survival prediction in SP2 (XGBoost-SP2) using BraTS17
validation dataset. The results are summarized in Table 1.
Using BraTS17 validation dataset, RF-SP1 model achieves 67.7%
accuracy, whereas XGBoost-SP2 model achieves 63.6%. Using
BraTS18 validation dataset, RF-SP1 model achieves 46.4%
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FIGURE 6 | The t-distributed stochastic neighbor embedding (t-SNE) of the
selected features of SP1 clustered based on their tissue types using BraTS17
(A) training; (B) validation; and (C) testing. Note that features are clustered
based on their origin (subtissue type).
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FIGURE 7 | (A) The 3D; and (B) the 2D plot of t-distributed stochastic neighbor embedding (t-SNE) of the selected features of SP1 clustered based on the long,
medium and short risk labels using BraTS17 training dataset.

accuracy, whereas XGBoost-SP2 model achieves 67.9% accuracy.
These results indicate that the XGBoost-SP2 combination
performs considerably better than that of RF-SP1 with BraTS18

Frontiers in Neuroscience | www.frontiersin.org

dataset and reasonably well with BraTS17 dataset, respectively.
Note that the ground truth of BraTS17 and BraTS18 validation
dataset are not provided. As a result, we have segmented BraTS17
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Comparison of Survival Prediction With
State-of-the-Art Works

Feature visualization for different sub-tissue types
0
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Comparison of the proposed survival prediction pipelines
SP1 and SP2 with few state-of-the-art methods in literature
is discussed next. Table 5 summarizes the performances
of these state-of-the-art models and presents a comparison
with our proposed framework (SP2). Chato et al. (2018)
propose using histogram features extracted from denoised
MR images (by using 2 level Daubechies wavelet transform)
in a support vector machine to predict overall survival.
Their method achieves a 10-fold cross validation accuracy
of 0.667 using BraTS17 training dataset. Kao et al. (2018)
extract volumetric, spatial, morphological, and tractographic
features from MR images. Feature normalization and selection
is performed, and the selected features are trained in a
support vector machine model. Their proposed model achieves
an accuracy of 0.7 using BraTS18 training dataset and an
accuracy of 0.5 using BraTS18 validation dataset. Soltaninejad
et al. (2017) utilize volumetric features along with RF to
predict overall survival. Their method achieves five-fold cross
validation accuracy of 0.638 using BraTS17 training dataset.
The results demonstrate that our proposed framework achieves
a higher accuracy in overall survival prediction compared
to the current-state-of-the-art models applied to the same
datasets. Note that, unlike our proposed SP1 and SP2 pipelines,
the reported performance for all these other methods in
Table 5 are obtained by the authors themselves. In addition,
a comparison between the performance of our segmentation
model and state-of-the-art models is illustrated in Table 6.
Though the abnormal brain tumor tissue segmentation results
for other methods in the 2018 Challenge (as shown in
Table 6) are better than our semantic-label fusion method,
our segmentation results are useful to offer the best survival
prediction performance in the 2018 BraTS Challenge as shown
in Table 1.
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In order to reduce the high dimensionality of the features
in SP2 classification and regression steps, we modify SP2
in Figure 3B as follows: (1) calculate and rank the feature
importance for each classification and regression model;
(2) select features that have a relative scaled importance
greater than 50%; and (3) train the modified selected
features in a new classification and regression training models
utilizing XGBoost.
The resulting 30 significant features are applied in the
classification step of the modified-SP2. The distribution of these
features is as follows: 13 features represent Euler characteristics,
7 features represent volumetric and area-related properties,
4 histogram-graph based features, 5 texture features, and one
feature with Age information.
The number of significant features used in the short-,
medium-, and long-regression models of the modified-SP2
is 11, 9, and 11, respectively. The distribution of the features
in the modified short-regression model are as follows: 2
volumetric and area-related features, 1 histogram-graph
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FIGURE 8 | The t-distributed stochastic neighbor embedding (t-SNE) of the
selected features of SP2 clustered based on their tissue types using BraTS18
(A) training; (B) validation; and (C) testing. Note that features are clustered
based on their origin (subtissue type).

and BraTS18 validation dataset using the semantic label fusion
model of CNN and RF (Vidyaratne et al., 2018) and the semantic
label fusion of U-Net and FCN, respectively.
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FIGURE 9 | (A) The 3D plot of the t-distributed stochastic neighbor embedding (t-SNE) of the selected features of SP2 clustered based on the long, medium and
short risk labels using BraTS18 training dataset. (B) The 2D plot of the same training dataset.

based features, 7 texture features, and one feature with Age
information. The features employed in the modified medregression model are 5 volumetric and area-related features,
3 texture features, and Age. Whereas the features of the
modified long-regression model are 2 volumetric and arearelated features, 8 texture features, and one feature with
Age information.
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The modified-SP2 achieves cross-validated accuracy of 0.718
as illustrated in Table 1. Table 3 illustrates the statistics
of its confusion matrix in the classification training model.
Table 4 illustrates the performance of the modified regression
training models. Additionally, the modified-SP2 is validated
using BraTS18 validation set and its performance is illustrated
in Table 1. Note that the different performances of SP2 and
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TABLE 5 | Comparison of our proposed survival prediction pipeline with state-of-the-art methods in literature.
References

Algorithm

Validation method

Chato et al., 2018

Histogram features along with SVM

10-fold cross validation

accuracy of 0.667

BraTS17 training dataset

Kao et al., 2018

Volumetric, spatial, morphological, and
tractographic features along with SVM

5-fold cross-validation

Accuracy of 0.7

BraTS18 training dataset

Soltaninejad et al., 2017

Volumetric features along with Random Forest

5-fold cross validation

Accuracy of 0.638

BraTS17 training dataset

XGBOOST overall survival
prediction model (SP2)

Texture, volumetric, histogram-graph, and
Euler features Along with XGBoost

LOOCV

Accuracy of 0.73 and
MSE of 91585.51

BraTS18 training dataset

Validation dataset

Accuracy of 0.679 and
MSE of 153466.3

BraTS18 validation dataset

modified-SP2 are almost similar when using the BraTS18 training
and validation dataset statistics of each class in SP2 and the
modified-SP2 are almost similar. This can be explained by the fact
that XGBoost provides L1 and L2 regularization.
Additionally, the modified-SP2 is validated using BraTS18
validation set and its performance is illustrated in Table 1.

Performance

Dataset

from the subtissues (edema, enhance tumor, and necrosis) and a
two-step classification and regression method. Different studies
(Pierallini et al., 1998; Lacroix et al., 2001; Maldaun et al.,
2004; Jain et al., 2014) correlate between survival prediction in
glioblastoma and different subtissues. SP2 shows improvements
over our primary survival prediction model (SP1) (Shboul et al.,
2017) with LOOCV accuracy increase to 0.73 from 0.67 for
training datasets. Whereas the modified-SP2 achieves crossvalidation accuracy of 0.718 using the training dataset.
There are a few limitations of the proposed work. First,
even though the total number of cases for survival training
dataset is 163, both BraTS 2017 and BraTS 2018 required that
the data must be divided into three separate survival-group
regression models. Consequently, the number of training cases
are divided among three models as follows: 65 cases for short-,
42 cases for medium- and 56 cases for long-regression models,
respectively. A larger dataset may be required when training
each regression model to improve the performance. Second, this
study may benefit from additional clinical data such as Gender
and Karnofsky Status to strengthen the reliability of the different
survival regression and classification models. Finally, the overall
survival risk classification performance of the state-of-the-art
methods in literature, including the pipelines proposed in this
work, may be improved further. The visualization of survival
features suggests the difficulty in separating the high dimensional
data into the three distinctive risk classes. This suggests the need
for further research in novel feature engineering for survival
prediction. Following the efficacy of deep radiomics features
in the tumor segmentation step, a possible future direction to
further improve the risk classification performance may involve
use of deep learning methods to learn all possible features in the
survival pipeline.

DISCUSSION AND FUTURE WORKS
This work proposes a novel framework for fully automated
deep radiomics-based Glioblastoma segmentation and survival
prediction. The overall framework is designed as two-step
process where automated tumor segmentation is carried out
in the first step, and the segmentation outcome is then
used for survival prediction in the second step. The accurate
segmentation of abnormal tissue tumor types such as necrosis,
edema, and enhancing tissue is critical to ensure robust
survival prediction performance. Consequently, several deep
learning- and radiomic-feature based segmentation algorithms,
and a semantic label fusion are introduced to obtain sufficient
segmentation performance. The framework also includes two
survival prediction algorithms SP1 and SP2 in step two,
represented by the use of feature types, feature selection,
regression and classification methods.
The primary survival pipeline (SP1) combines patch-wise
CNN based algorithm and radiomics based algorithm using
label fusion for segmentation, and applies the RF based survival
prediction algorithm to obtain the final output. The second
pipeline (SP2) combines U-Net and FCN segmentation with
an XGBoost based survival prediction algorithm. As shown in
Figure 1, the features used in both SP2 and SP1 offers an excellent
segmentation of different abnormal tissue type. The functionality
of SP2 is further enhanced by using additional features extracted
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TABLE 6 | Comparison to our proposed with state-of-art models that have used
BraTS18 testing dataset.
Dice enhanced Dice whole Dice tumor
References

tumor

tumor

core

Semantic-label fusion method (SP2)

0.705

0.857

0.767

Myronenko, 2018

0.766

0.884

0.815

Isensee et al., 2018

0.779

0.878

0.806

Zhou et al., 2018

0.778

0.884

0.796
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